These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27009842)

  • 1. Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression.
    Lasorsa VA; Formicola D; Pignataro P; Cimmino F; Calabrese FM; Mora J; Esposito MR; Pantile M; Zanon C; De Mariano M; Longo L; Hogarty MD; de Torres C; Tonini GP; Iolascon A; Capasso M
    Oncotarget; 2016 Apr; 7(16):21840-52. PubMed ID: 27009842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic landscape of high-risk neuroblastoma.
    Pugh TJ; Morozova O; Attiyeh EF; Asgharzadeh S; Wei JS; Auclair D; Carter SL; Cibulskis K; Hanna M; Kiezun A; Kim J; Lawrence MS; Lichenstein L; McKenna A; Pedamallu CS; Ramos AH; Shefler E; Sivachenko A; Sougnez C; Stewart C; Ally A; Birol I; Chiu R; Corbett RD; Hirst M; Jackman SD; Kamoh B; Khodabakshi AH; Krzywinski M; Lo A; Moore RA; Mungall KL; Qian J; Tam A; Thiessen N; Zhao Y; Cole KA; Diamond M; Diskin SJ; Mosse YP; Wood AC; Ji L; Sposto R; Badgett T; London WB; Moyer Y; Gastier-Foster JM; Smith MA; Guidry Auvil JM; Gerhard DS; Hogarty MD; Jones SJ; Lander ES; Gabriel SB; Getz G; Seeger RC; Khan J; Marra MA; Meyerson M; Maris JM
    Nat Genet; 2013 Mar; 45(3):279-84. PubMed ID: 23334666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.
    Shukla N; Ameur N; Yilmaz I; Nafa K; Lau CY; Marchetti A; Borsu L; Barr FG; Ladanyi M
    Clin Cancer Res; 2012 Feb; 18(3):748-57. PubMed ID: 22142829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.
    Esposito MR; Binatti A; Pantile M; Coppe A; Mazzocco K; Longo L; Capasso M; Lasorsa VA; Luksch R; Bortoluzzi S; Tonini GP
    Int J Cancer; 2018 Nov; 143(10):2525-2536. PubMed ID: 29992558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
    Roth SA; Knutsen E; Fiskaa T; Utnes P; Bhavsar S; Hald ØH; Løkke C; Mestdagh P; Johansen SD; Flægstad T; Einvik C
    Cancer Lett; 2016 Mar; 372(1):128-36. PubMed ID: 26708804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
    Fransson S; Martinez-Monleon A; Johansson M; Sjöberg RM; Björklund C; Ljungman G; Ek T; Kogner P; Martinsson T
    Sci Rep; 2020 Dec; 10(1):22432. PubMed ID: 33384420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.
    Bellini A; Bernard V; Leroy Q; Rio Frio T; Pierron G; Combaret V; Lapouble E; Clement N; Rubie H; Thebaud E; Chastagner P; Defachelles AS; Bergeron C; Buchbinder N; Taque S; Auvrignon A; Valteau-Couanet D; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
    Clin Cancer Res; 2015 Nov; 21(21):4913-21. PubMed ID: 26059187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
    Padovan-Merhar OM; Raman P; Ostrovnaya I; Kalletla K; Rubnitz KR; Sanford EM; Ali SM; Miller VA; Mossé YP; Granger MP; Weiss B; Maris JM; Modak S
    PLoS Genet; 2016 Dec; 12(12):e1006501. PubMed ID: 27997549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma.
    Calabrese FM; Clima R; Pignataro P; Lasorsa VA; Hogarty MD; Castellano A; Conte M; Tonini GP; Iolascon A; Gasparre G; Capasso M
    Oncotarget; 2016 Aug; 7(31):49246-49258. PubMed ID: 27351283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations.
    Brady SW; Liu Y; Ma X; Gout AM; Hagiwara K; Zhou X; Wang J; Macias M; Chen X; Easton J; Mulder HL; Rusch M; Wang L; Nakitandwe J; Lei S; Davis EM; Naranjo A; Cheng C; Maris JM; Downing JR; Cheung NV; Hogarty MD; Dyer MA; Zhang J
    Nat Commun; 2020 Oct; 11(1):5183. PubMed ID: 33056981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Alterations Detected by Targeted Next-generation Sequencing and Their Clinical Implications in Neuroblastoma.
    Koh KN; Lee JY; Lim J; Shin J; Kang SH; Suh JK; Kim H; Im HJ; Namgoong JM; Kim DY; Jang SJ; Chun SM
    Anticancer Res; 2020 Dec; 40(12):7057-7065. PubMed ID: 33288603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
    Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
    Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumor progression and unresponsiveness to therapy.
    Martinsson T; Eriksson T; Abrahamsson J; Caren H; Hansson M; Kogner P; Kamaraj S; Schönherr C; Weinmar J; Ruuth K; Palmer RH; Hallberg B
    Cancer Res; 2011 Jan; 71(1):98-105. PubMed ID: 21059859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research progress of neuroblastoma related gene variations.
    Cao Y; Jin Y; Yu J; Wang J; Yan J; Zhao Q
    Oncotarget; 2017 Mar; 8(11):18444-18455. PubMed ID: 28055978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational dynamics between primary and relapse neuroblastomas.
    Schramm A; Köster J; Assenov Y; Althoff K; Peifer M; Mahlow E; Odersky A; Beisser D; Ernst C; Henssen AG; Stephan H; Schröder C; Heukamp L; Engesser A; Kahlert Y; Theissen J; Hero B; Roels F; Altmüller J; Nürnberg P; Astrahantseff K; Gloeckner C; De Preter K; Plass C; Lee S; Lode HN; Henrich KO; Gartlgruber M; Speleman F; Schmezer P; Westermann F; Rahmann S; Fischer M; Eggert A; Schulte JH
    Nat Genet; 2015 Aug; 47(8):872-7. PubMed ID: 26121086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
    Bellini A; Bessoltane-Bentahar N; Bhalshankar J; Clement N; Raynal V; Baulande S; Bernard V; Danzon A; Chicard M; Colmet-Daage L; Pierron G; Le Roux L; Planchon JM; Combaret V; Lapouble E; Corradini N; Thebaud E; Gambart M; Valteau-Couanet D; Michon J; Louis-Brennetot C; Janoueix-Lerosey I; Defachelles AS; Bourdeaut F; Delattre O; Schleiermacher G
    Int J Cancer; 2019 Nov; 145(10):2781-2791. PubMed ID: 31018240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing of rare aggressive breast cancer histologies.
    Dieci MV; Smutná V; Scott V; Yin G; Xu R; Vielh P; Mathieu MC; Vicier C; Laporte M; Drusch F; Guarneri V; Conte P; Delaloge S; Lacroix L; Fromigué O; André F; Lefebvre C
    Breast Cancer Res Treat; 2016 Feb; 156(1):21-32. PubMed ID: 26907767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
    Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
    Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.